Antipsychotic method

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514340, 514362, 514318, 514333, 514336, 5142362, A61K 31445, A61K 3141, C07D41704, C07D41304

Patent

active

057536830

ABSTRACT:
The present invention relates to a novel method for treating a mammal suffering from or susceptible to schizophrenia and schizophreniform diseases.

REFERENCES:
patent: 4837241 (1989-06-01), Jensen et al.
patent: 4866077 (1989-09-01), Bogeso et al.
patent: 4952587 (1990-08-01), Baker et al.
patent: 4977176 (1990-12-01), Amstutz et al.
patent: 5041455 (1991-08-01), Sauerberg et al.
patent: 5086053 (1992-02-01), Broden et al.
patent: 5260311 (1993-11-01), Sauerberg et al.
patent: 5324723 (1994-06-01), Baker et al.
patent: 5328925 (1994-07-01), Sauerberg et al.
patent: 5330994 (1994-07-01), Pei et al.
Karson, et al., Psychiatry Research: Neuroimaging, vol. 40, pp. 31-48, (1991).
Chalmers, et al., Psychopharmacologia, vol. 6, pp. 31-41, (1964).
Tandom, et al. (I), Arch. Gen. Psychiatry, vol. 46, pp. 745-753 (1989).
Weiner, et al., Proc. Natl. Acad. Sci. USA, vol. 87, pp. 7050-7054 (1990).
Abstracts -Society for Neuroscience-vol. 18, 1992.
Letters to Editor, Arch. Gen. Psychiatry, vol. 48, pp. 1112-1114, (1991).
Pfeiffer, et al., Muscarinic Stimulation of the Brain:Annals New York Academy of Sciences, pp. 753-764, 1957.
Crocker, et al., Neuroscience Letters, vol. 142, pp. 73-76 (1992).
Strauss, et al., Schizophrenia Research, vol. 3, pp. 127-129 (1990).
Tandon, et al. (II), Schizophrenia Research, vol. 4, pp. 23-30 (1991).
Arnt et al., European Jour. of Pharmacology, vol. 69, pp. 107-111 (1981).
Iorio et al., Jour. of Pharmacology & Experimental Therapeutics, vol. 258, No. 1 (1991).
Rodriguez, R., Pharmacology Biochemistry and Behavior, vol. 43, pp. 1155-1159 (1992).
Philippens, et al., Pharmacology Biochemistry and Behavior, vol. 42, pp. 285-289 (1992).
Ricmann, et al., Abstract-Cholinergic Stimulation and Rem Sleep in Depression and Schizophrenia.
Karson, et al., Abstract -The Brainstem Reticular Formation in Schizophrenia.
Chem. Abs. No. 97:125278 of Neurobiol., Vienna, A-1130, Austria, Riederer et al, "Morphological and Biochemical changes in aging . . . " (1982).
Chem. Abs. No. 113:113093 of J. FASEB, 4(10), 2707-(8), Snyder et al, "Receptor-channel alterations in disease", (1990).
Chem. Abs. No. 112:116685 of Proc. Natl. Acad. Sci. U.S.A. 86(24), 10156-60, Seaman et al, "Link between D.sub.1 and D.sub.2 dopamine receptors . . . ", (1989).
Chem. Abs. No. 111:17728 of DE 3811274, Sandoz-Patent, Markstein et al, "Dopamine receptor antagonists . . . ", (1988).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antipsychotic method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antipsychotic method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antipsychotic method will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1853446

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.